Similar Articles
Juvenile Scleroderma: Apropos of Two Cases
Belde Kasap, Alper Soylu, Mehmet Türkmen, Salih Kavukçu
Systemic Sclerosis is Not Associated with Increased Coronary Artery Calcium Deposition
Lee SEUNG-GEUN, Park YOUNG-EUN, Choi SU-YEON, Park EUN-KYUNG, Kim GEUN-TAE, Choo KI-SEOK, Jeong YEON-JOO
DOI: 10.5606/tjr.2013.3625
Letrozole-Induced Very Early Systemic Sclerosis in a Patient With Breast Cancer: A Case Report
Gabriel POKHAI, Rino BUZZOLA, Adriana ABRUDESCU
DOI: 10.5606/ArchRheumatol.2014.3429
Coexistence of Ankylosing Spondylitis With Morphea: A Case Report
Kevser GÜMÜŞSU, Aylin REZVANİ, Özlem SU, Nihal ÖZARAS, Mustafa GÜLER
DOI: 10.5606/ArchRheumatol.2014.3919
Systemic Scleroderma in Childhood: A Case Report
Aslı ASLAN, Güldane KOTUROĞLU, Betül SÖZERİ, Zafer KURUGÖL
DOI: 10.5606/ArchRheumatol.2014.3684
A Cross Sectional Study of Cardiopulmonary Complications and Severity of Pulmonary Hypertension and Lung Fibrosis in Patients With Systemic Sclerosis
Wan Ahmad Syahril Rozli WAN ALI, Mohd Shahrir MOHAMED SAID, Syahrul Sazliyana SHAHARIR, Andrea Yu Lin BAN, Rizuana Iqbal HUSSAIN, Azmillah ROSMAN
DOI: 10.5606/ArchRheumatol.2015.5593
Clinical Usefulness of Magnetic Resonance Imaging in Four Children With Scleroderma
Kazushi AGATA, Hisashi KAWASHIMA, Atsushi KUMADA, Yasuyo KASHIWAGI, Hiroko HARA
DOI: 10.5606/ArchRheumatol.2018.6498
Paricalcitol Inhibits Wnt/β-Catenin Signaling Pathway and Ameliorates Dermal Fibrosis in Bleomycin Induced Scleroderma Model
Nevzat GÖZEL, Fikret DURAN, Ahmet YILDIRIM, Servet YOLBAŞ, Ebru ÖNALAN, İbrahim Hanifi ÖZERCAN, Süleyman Serdar KOCA
DOI: 10.5606/ArchRheumatol.2018.6648
Juvenile Scleroderma: A Referral Center Experience
Amra ADROVIC, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR
DOI: 10.5606/ArchRheumatol.2018.6578
Antioxidant Effect of Epigallocatechin-3-Gallate in a Bleomycin-Induced Scleroderma Model
Ayse KOÇAK, Duygu HARMANCI, Zahide ÇAVDAR, Cemre URAL, Merih BİRLİK, Sülen SARIOĞLU, Osman YILMAZ, Gül GÜNER AKDOĞAN
DOI: 10.5606/ArchRheumatol.2019.6835
Prevalence, Risk Factors and Assessment of Depressive Symptoms in Patients With Systemic Sclerosis
Christine MARCH, Dörte HUSCHER, Emelina PREIS, Alexander MAKOWKA, Jakob HOEPPNER, Frank BUTTGEREIT, Gabriela RIEMEKASTEN, Kristina NORMAN, Elise SIEGERT
DOI: 10.5606/ArchRheumatol.2019.7111
A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study
Kyung-Ann LEE, Bo Young KIM, Sung Jae CHOI, Seong-Kyu KIM, Sang-Hyon KIM, Hyun-Sook KIM
DOI: 10.46497/ArchRheumatol.2020.7771
A preliminary study of possible fibrotic role of meprin metalloproteases in scleroderma patients
Ayşe Koçak, Aydan Köken Avşar, Duygu Harmancı, Gül Akdoğan, A. Merih Birlik
DOI: 10.46497/ArchRheumatol.2021.8581
Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease
Biqing Huang, Jing Li, Jiuliang Zhao
DOI: 10.46497/ArchRheumatol.2021.8625
Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan
Sadia Asif, Asadullah Khan, Muhammad Faiq, Zia Ud Din, Sarmad Zahoor, Muhammad Haroon
DOI: 10.46497/ArchRheumatol.2021.8701
Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis
Fulden Sari, Zilan Bazancir Apaydin, Hakan Apaydin, Mehmet Kayaalp, Abdulsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Kucuksahin, Şükran Erten
DOI: 10.46497/ArchRheumatol.2023.10183
Males and females with scleroderma: A comparative study in a Brazilian sample
Matheus Costa, Igor Jorge, Patricia Martin, Renato Nisihara, Thelma Skare
DOI: 10.46497/ArchRheumatol.2023.10011